Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Frontiers in Medicine|February 2, 2023
Targeted thorium-227 conjugates as treatment options in oncologyJenny Karlsson, Christoph A Schatz, Antje M Wengner, et al.
Molecular Cancer Therapeutics|August 19, 2016
In Vitro and In Vivo Efficacy of a Novel CD33-Targeted Thorium-227 Conjugate for the Treatment of Acute Myeloid LeukemiaUrs B Hagemann, Katrine Wickstroem, Ellen Wang, et al.
International Journal of Molecular Sciences|January 8, 2025
Darolutamide in Combination with Radium-223 Exhibits Synergistic Antitumor Efficacy in LNCaP Prostate Cancer ModelsUrs B Hagemann, Christoph A Schatz, Mari I Suominen, et al.
Pharmaceuticals (Basel, Switzerland)|October 18, 2019
Synergistic Effect of a HER2 Targeted Thorium-227 Conjugate in Combination with Olaparib in a BRCA2 Deficient Xenograft ModelKatrine Wickstroem, Jenny Karlsson, Christine Ellingsen, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 8, 2020
Advances in Precision Oncology: Targeted Thorium-227 Conjugates As a New Modality in Targeted Alpha TherapyUrs B Hagemann, Katrine Wickstroem, Stefanie Hammer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 1, 2025
Biodistribution of free Francium-221 and Bismuth-213 in Tumour-bearing SCID mice after successful development of Actinium-225/Francium-221 radionuclide generator Set-upSabine Zitzmann-Kolbe, Yvonne Remde, Ingrid Moen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 10, 2019
Synergistic Effect of a Mesothelin-Targeted 227Th Conjugate in Combination with DNA Damage Response Inhibitors in Ovarian Cancer Xenograft ModelsKatrine Wickstroem, Urs B Hagemann, Véronique Cruciani, et al.
Cancers|July 14, 2023
Efficacy of a HER2-Targeted Thorium-227 Conjugate in a HER2-Positive Breast Cancer Bone Metastasis ModelJenny Karlsson, Urs B Hagemann, Véronique Cruciani, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 20, 2021
In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody AnetumabJyoti Roy, Elaine M Jagoda, Falguni Basuli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 26, 2021
Darolutamide Potentiates the Antitumor Efficacy of a PSMA-targeted Thorium-227 Conjugate by a Dual Mode of Action in Prostate Cancer ModelsStefanie Hammer, Andreas Schlicker, Sabine Zitzmann-Kolbe, et al.
Pageof 3